EDGAR Filing Documents for 0001437749-17-019375

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001437749-17-019375

Filing Date

2017-11-14

Accepted

2017-11-14 16:41:47

Documents

Period of Report

2017-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	kool20170930_10q.htm	10-Q	577232
2	EXHIBIT 31.1	ex_100156.htm	EX-31.1	9857
3	EXHIBIT 31.2	ex_100157.htm	EX-31.2	9177
4	EXHIBIT 32	ex_100158.htm	EX-32	6763
	Complete submission text file	0001437749-17-019375.txt		3637119

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	kool-20170930.xml	EX-101.INS	668504
6	XBRL TAXONOMY EXTENSION SCHEMA	kool-20170930.xsd	EX-101.SCH	41652
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	kool-20170930_cal.xml	EX-101.CAL	34364
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	kool-20170930_def.xml	EX-101.DEF	296542
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	kool-20170930_lab.xml	EX-101.LAB	272533
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	kool-20170930_pre.xml	EX-101.PRE	317285

Mailing Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742

Business Address 2711 CITRUS ROAD RANCHO CORDOVA CA 95742 9168585100

CESCA THERAPEUTICS INC. (Filer) CIK: 0000811212 (see all company filings)